|
| Correlations between pathological and SUVmax values | ||
| Number (%) | SUVmax | P value | |
| Tumor invasive size |
|
|
|
| T1 | 36 (49.3) | 3.95 ± 3.28 | <0.001 |
| T2 | 37 (50.7) | 7.23 ± 4.10 |
|
| ER status |
|
|
|
| Positive | 56 (76.7) | 4.62 ± 3.61 | <0.001 |
| Negative | 17 (23.3) | 8.90 ± 3.73 |
|
| PR status |
|
|
|
| Positive | 42 (57.5) | 4.75 ± 3.94 | 0.0134 |
| Negative | 31 (42.5) | 6.79 ± 3.95 |
|
| HER2 status |
|
|
|
| Positive | 10 (13.7) | 8.66 ± 4.98 | 0.0176 |
| Negative | 63 (86.3) | 5.17 ± 3.70 |
|
| Ki-67 index (%) |
|
|
|
| <14 | 28 (38.4) | 3.24 ± 2.58 | <0.001 |
| ≥14 | 45 (61.6) | 7.10 ± 4.11 |
|
| Nuclear grade |
|
|
|
| 1 | 38 (52.1) | 3.85 ± 3.15 | <0.001 |
| 2 | 17 (23.3) | 6.79 ± 3.50 |
|
| 3 | 18 (24.6) | 7.60 ± 3.73 |
|